TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16891384

Group type: EXPERIMENTAL
Intervention: Suprathreshold 1 Hz rTMS (30 min) applied to the region with maximal tinnitus-related increase in regional cerebral blood flow
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Suprathreshold 1 Hz rTMS
Number of subjects: 6
Study: 15530150

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fish oil (1.35 g n‐3 fatty acids)
Number of subjects: 11
Study: 11523612

Group type: EXPERIMENTAL
Intervention: Intravenous dofetilide
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9692655

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7841566

Group type: EXPERIMENTAL
Intervention: Nimodipine 0.4 mg/h
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nimodipine 1 mg/h
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nimodipine 2 mg/h
Number of subjects: 61

Group type: COMPARATOR
Intervention: Vehicle 10 mL/h
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo 10 mL/h
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nimodipine 0.4 mg/h and 1 mg/h
Number of subjects: 61
Study: 3073766

Group type: EXPERIMENTAL
Intervention: Intraarterial infusion therapy with prostaglandin E1 (PGE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Infusion therapy with energy rich phosphates (ERP)
Number of subjects: 40
Study: 29968385

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of oral drotaverine hydrochloride (80 mg) and paracetamol (500 mg)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Oral paracetamol (500 mg) three times a day for 3 days
Number of subjects: 252
Study: 28448784

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) telephone intervention conducted by pharmacy students, including an initial call and 5 monthly follow-up calls.
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) telephone intervention conducted by pharmacy students.
Number of subjects: 743

Group type: COMPARATOR
Intervention: Control group (no MI intervention).
Number of subjects: 743
Study: 25614134

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brace (lateral counterforce brace)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo HILT (sham therapy group)
Number of subjects: 0
Study: 23924198

Group type: EXPERIMENTAL
Intervention: Bridge plate surgery
Number of subjects: 110

Group type: COMPARATOR
Intervention: Functional brace
Number of subjects: 110
Study: 21044518

Group type: EXPERIMENTAL
Intervention: Copy the target word from the computer screen (n=22)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Memorize the target word and write it from memory (n=21)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Word reading (n=21)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Untrained control group (n=21)
Number of subjects: 85
Study: 18459541

Group type: EXPERIMENTAL
Intervention: Piver type II hysterectomy
Number of subjects: 0
Study: 17052306

Group type: EXPERIMENTAL
Intervention: Budesonide 200 microg (for patients aged<11 years) or 400 microg administered via Turbuhaler
Number of subjects: 6656

Group type: COMPARATOR
Intervention: Placebo plus usual asthma therapy
Number of subjects: 6656
Study: 14641507

Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 11011847

Group type: EXPERIMENTAL
Intervention: 5 mg folic acid, 0.4 mg vitamin B12 and 50 mg vitamin B6
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 9309533

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg/die orally for 7 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 14
Study: 8339552

Group type: EXPERIMENTAL
Intervention: Dietary changes alone
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Combination of dietary changes and exercise
Number of subjects: 219

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 219
Study: 3730230

Group type: EXPERIMENTAL
Intervention: Alcuronium 0.15, 0.2 or 0.3 mg kg‐1 with priming
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Alcuronium 0.04 mg kg‐1 given 30 s after induction
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Alcuronium 0.3 mg kg‐1 with increased priming portion
Number of subjects: 72
Study: 29504342

Group type: EXPERIMENTAL
Intervention: Physio dispenser group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Slow speed handpiece group
Number of subjects: 60
Study: 27388213

Group type: EXPERIMENTAL
Intervention: ACL reconstruction using a distally inserted hamstring graft (HG) with tibial insertion preservation
Number of subjects: 40

Group type: COMPARATOR
Intervention: ACL reconstruction with hamstring graft (HG) tibial detachment
Number of subjects: 40
Study: 25008027

Group type: EXPERIMENTAL
Intervention: Prasugrel 5-mg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Prasugrel 10-mg
Number of subjects: 195

Group type: COMPARATOR
Intervention: Clopidogrel 75-mg
Number of subjects: 195
Study: 23433324

Group type: EXPERIMENTAL
Intervention: 500 mg of intramuscular 17P, repeated twice weekly until 36 weeks or preterm delivery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study: 20101185

Group type: EXPERIMENTAL
Intervention: Risperidone long-acting therapy (RLAT) 25 or 50 mg every 2 weeks
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Risperidone long-acting therapy (RLAT)
Number of subjects: 323
Study: 18439282

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Ultrasound physical therapy (UPT)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 488
Study: 16169350

Group type: EXPERIMENTAL
Intervention: Group II (previous PCI of original target lesion)
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Group III (previous PCI of nontarget lesion)
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Group I (no previous PCI)
Number of subjects: 10000
Study: 12672938

Group type: EXPERIMENTAL
Intervention: Combined supplementation with 91 mg (136 iu) α-tocopherol and 250 mg of slow-release vitamin C twice a day for 3 years
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 10533869

Group type: EXPERIMENTAL
Intervention: Female condom introduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8910177

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 555

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 555
Study: 1908372

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms q.i.d. for 4 weeks
Number of subjects: 94

Group type: COMPARATOR
Intervention: Cimetidine 200 mg q.i.d. for 4 weeks
Number of subjects: 94
Study: 6857507

Group type: EXPERIMENTAL
Intervention: Electrical calf stimulation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low‐dose subcutaneous heparin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intermittent sequential compression and thromboembolism‐deterrent (TED) stockings
Number of subjects: 150
Study: 31004134

Group type: COMPARATOR
Intervention: NaPP:57Fe ratio 0:1
Number of subjects: 24

Group type: COMPARATOR
Intervention: NaPP:57Fe ratio 3:1
Number of subjects: 24

Group type: COMPARATOR
Intervention: NaPP:57Fe ratio 6:1
Number of subjects: 24
Study: 30066681

Group type: EXPERIMENTAL
Intervention: Self-adhering flowable composite (Fusio liquid dentin)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional flowable composite (Tetric Flow)
Number of subjects: 20
Study: 25583271

Group type: EXPERIMENTAL
Intervention: Modular treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard manualized treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 24507754

Group type: EXPERIMENTAL
Intervention: Warming blood transfusion and infusion (WBI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (standard blood transfusion)
Number of subjects: 80
Study: 22484582

Group type: EXPERIMENTAL
Intervention: CTLA4Ig gene transfer via adenovirus vector (Ad‐CTLA4Ig‐EGFP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no CTLA4Ig gene transfer)
Number of subjects: 0
Study: 21129689

Group type: EXPERIMENTAL
Intervention: Educational Intervention (EI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (pre-EI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (post-EI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (ICM use)
Number of subjects: 21
Study: 17456287

Group type: EXPERIMENTAL
Intervention: Cognitive processing of food cues in overweight adolescents
Number of subjects: 87

Group type: COMPARATOR
Intervention: Cognitive processing of food cues in normal weight adolescents
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Thought suppression instruction
Number of subjects: 87
Study: 15780039

Group type: EXPERIMENTAL
Intervention: Screening for breast cancer (mammography)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening for breast cancer (alternative methods)
Number of subjects: 0
Study: 12065142

Group type: EXPERIMENTAL
Intervention: Active management of the third stage of labor with uterotonic drugs (Oxytocin preferred)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active management of the third stage of labor
Number of subjects: 0
Study: 9728155

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 1172

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 1172
Study: 8539677

Group type: EXPERIMENTAL
Intervention: CPAP titration using full polysomnography
Number of subjects: 41

Group type: COMPARATOR
Intervention: CPAP titration using night time respiratory recordings
Number of subjects: 41
Study: 2482193

Group type: EXPERIMENTAL
Intervention: Anthracyclines 0.2 mumol/l
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ara-C 0.5 mumol/l
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of anthracyclines and Ara-C
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Incubations with 0.2 mumol/l anthracyclines and 0.5 mumol/l Ara-C
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: In vitro drug sensitivity
Number of subjects: 40
Study: 754843

Group type: EXPERIMENTAL
Intervention: Routine pubic shaving prior to transurethral surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: No pubic shave
Number of subjects: 0
Study: 30728055

Group type: EXPERIMENTAL
Intervention: Immersive VR and conventional rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 60
Study: 27932540

Group type: EXPERIMENTAL
Intervention: Self-help autogenic relaxation CD listened to five times a week for one month
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group received treatment after three months
Number of subjects: 15
Study: 26022802

Group type: EXPERIMENTAL
Intervention: Stress condition
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Food cues condition
Number of subjects: 133
Study: 23670112

Group type: EXPERIMENTAL
Intervention: Two-session intervention aimed at increasing adherence via implementation intentions and modifying mistaken beliefs about medication/stroke.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 62
Study: 21300940

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (20 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 19552805

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 132

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection with physiotherapy (8 sessions over 8 weeks)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Saline injection with physiotherapy (8 sessions over 8 weeks)
Number of subjects: 132
Study: 17342556

Group type: EXPERIMENTAL
Intervention: Laparoscopic colon resection (LCR)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Open colon resection (OCR)
Number of subjects: 285
Study: 16132320

Group type: EXPERIMENTAL
Intervention: Physical training system
Number of subjects: 32

Group type: COMPARATOR
Intervention: Virtual reality training system
Number of subjects: 32
Study: 11943519

Group type: EXPERIMENTAL
Intervention: Bupivacaine 180 mg with midazolam 20 mg (HM group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bupivacaine 90 mg with midazolam 20 mg (LM group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine 180 mg without midazolam (HC group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bupivacaine 90 mg without midazolam (LC group)
Number of subjects: 100
Study: 9495418

Group type: EXPERIMENTAL
Intervention: Epidural infusion of alfentanil (0.36 mg/h) plus bupivacaine (10 mg/h)
Number of subjects: 32

Group type: COMPARATOR
Intervention: i.v. infusion of alfentanil (0.36 mg/h) plus bupivacaine (10 mg/h)
Number of subjects: 32
Study: 7710445

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.i.d. and clarithromycin 500 mg q.i.d. (group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg q.i.d. and clarithromycin 500 mg q.i.d. (group 2)
Number of subjects: 40
Study: 2468702

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1078803

Group type: EXPERIMENTAL
Intervention: Portacaval anastomosis (PCA)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control Group (unoperated)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups (Control and Shunt)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Shunt Group
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 108
Study: 30886131

Group type: EXPERIMENTAL
Intervention: Transversalis fascia plane (TFP) block with 20 ml of 0.5% ropivacaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transversalis fascia plane (TFP) block with 5% dextrose
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no TFP block)
Number of subjects: 50
Study: 28796053

Group type: EXPERIMENTAL
Intervention: 14-day berberine-containing quadruple therapy
Number of subjects: 612

Group type: COMPARATOR
Intervention: 14-day bismuth-containing quadruple therapy
Number of subjects: 612
Study: 26595030

Group type: EXPERIMENTAL
Intervention: Isolated abdominoplasty without rectus fascia plication
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Isolated abdominoplasty with rectus fascia plication
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Change in Short-Form physical function subscale after abdominoplasty
Number of subjects: 94
Study: 23174856

Group type: EXPERIMENTAL
Intervention: Nitrate-rich concentrated beetroot juice (BR; 2 × 70 ml/day, ∼9.6 mmol/day NO(3)(‐))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice placebo (PL; 2 × 70 ml/day, ∼0.01 mmol/day NO(3)(‐))
Number of subjects: 12
Study: 21774637

Group type: EXPERIMENTAL
Intervention: Teaching algorithms
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Teaching ECG
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Preparation without teaching
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Teaching vs Preparation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Teaching vs Preparation (60 days later)
Number of subjects: 17
Study: 19670454

Group type: EXPERIMENTAL
Intervention: Doxorubicin and gemcitabine (AG) followed by paclitaxel and cisplatin (Protocol A)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Doxorubicin and gemcitabine (AG) followed by paclitaxel plus carboplatin (Protocol B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgery alone (Control group)
Number of subjects: 50
Study: 15753134

Group type: EXPERIMENTAL
Intervention: High-fat meal (17.5 g fat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat meal (2.7 g fat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-fat toast and butter (17.5 g fat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (400 mg/day, 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ApoE3 subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: ApoE4 subjects
Number of subjects: 0
Study: 10519497

Group type: EXPERIMENTAL
Intervention: Mivazerol
Number of subjects: 1897

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1897
Study: 7742830

Group type: EXPERIMENTAL
Intervention: Oral theophylline (350 mg b.i.d.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2330167

Group type: EXPERIMENTAL
Intervention: Vacu‐Cut needle (19.5 G)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Menghini needle (17 G)
Number of subjects: 20
Study: 7016124

Group type: EXPERIMENTAL
Intervention: Praziquantel (1 x 30 mg/kg, 1 x 40 mg/kg, 2 x 20 mg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (1 x 40 mg/kg)
Number of subjects: 90
Study: 30715561

Group type: EXPERIMENTAL
Intervention: Orthogeriatric comanagement (OGC)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Geriatric Consultant Service (GCS)
Number of subjects: 430
Study: 28971980

Group type: EXPERIMENTAL
Intervention: Metabolomic profiling in Study B (n=166)
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Metabolomic profiling in Study A (n=423)
Number of subjects: 589
Study: 26073279

Group type: EXPERIMENTAL
Intervention: MDMA (100mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MDMA (100mg) + MDMA (100mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo + MDMA (100mg)
Number of subjects: 10
Study: 24322572

Group type: EXPERIMENTAL
Intervention: Low BIS (30‐40)
Number of subjects: 135

Group type: COMPARATOR
Intervention: High BIS (45‐60)
Number of subjects: 135
Study: 22665339

Group type: EXPERIMENTAL
Intervention: Bipolar plasmakinetic TURP (PK‐TURP)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Monopolar TURP (M‐TURP)
Number of subjects: 220
Study: 20081393

Group type: EXPERIMENTAL
Intervention: Multipronged intervention including staff training, couples family planning sessions, and free provision of hormonal contraception on‐site
Number of subjects: 213

Group type: COMPARATOR
Intervention: No intervention (other Kenyan sites)
Number of subjects: 213
Study: 17377889

Group type: EXPERIMENTAL
Intervention: Feedback provided to therapists after the first half of the chat session.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Non-feedback sessions (control group).
Number of subjects: 86
Study: 15385359

Group type: EXPERIMENTAL
Intervention: Isoflurane inhalation combined with positive pressure ventilation (PPV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total IV anesthesia (TIVA) combined with positive pressure ventilation (PPV)
Number of subjects: 40
Study: 11496849

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic-drug therapy
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Driving after resumption
Number of subjects: 758
Study: 9526748

Group type: EXPERIMENTAL
Intervention: Inter-examiner reliability assessment using mechanical pressure algometer
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intra-examiner reliability assessment
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inter-examiner coefficient of variation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intra-examiner coefficient of variation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inter-examiner coefficient of repeatability (CR)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intra-examiner coefficient of repeatability (CR)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Assessment of frontal point differences between examiners
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Assessment of non-significant points
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inter-examiner reliability of side differences
Number of subjects: 21
Study: 7913326

Group type: EXPERIMENTAL
Intervention: Zidovudine 500 mg twice daily for 104 weeks (initially 250 mg four times daily for the first 4 weeks)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo twice daily for 104 weeks
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329
Study: 31919579

Group type: EXPERIMENTAL
Intervention: Bilastine 10 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30169323

Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition (withholding for 1 week)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition
Number of subjects: 209

Group type: COMPARATOR
Intervention: Early parenteral nutrition (initiated within 24 h)
Number of subjects: 209
Study: 27566413

Group type: EXPERIMENTAL
Intervention: Belotecan/cisplatin (BP)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Etoposide/cisplatin (EP)
Number of subjects: 147
Study: 25648301

Group type: EXPERIMENTAL
Intervention: TRANSFoRm-supported recruitment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard opportunistic recruitment (Control)
Number of subjects: 0
Study: 22928590

Group type: EXPERIMENTAL
Intervention: BIS biosignal
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Entropy biosignal
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: BIS biosignal with 0.6 mg/kg rocuronium
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: BIS biosignal with 1.2 mg/kg rocuronium
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Entropy biosignal with 0.6 mg/kg rocuronium
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Entropy biosignal with 1.2 mg/kg rocuronium
Number of subjects: 34